IOVA |
IOVANCE BIOTHERAPEUTICS, INC. |
Dec 2, 2024 |
3 |
-$40.1K |
4 |
Dec 4, 2024 |
Interim CEO & General Counsel, Director |
IOVA |
IOVANCE BIOTHERAPEUTICS, INC. |
Oct 14, 2024 |
3 |
-$86.5K |
4 |
Oct 16, 2024 |
Interim CEO & General Counsel, Director |
IOVA |
IOVANCE BIOTHERAPEUTICS, INC. |
Sep 3, 2024 |
6 |
-$264K |
4 |
Sep 5, 2024 |
Interim CEO & General Counsel, Director |
IOVA |
IOVANCE BIOTHERAPEUTICS, INC. |
Jul 15, 2024 |
3 |
-$76.8K |
4 |
Jul 17, 2024 |
Interim CEO & General Counsel |
IOVA |
IOVANCE BIOTHERAPEUTICS, INC. |
Jun 3, 2024 |
3 |
-$37K |
4 |
Jun 5, 2024 |
Interim CEO & General Counsel |
IOVA |
IOVANCE BIOTHERAPEUTICS, INC. |
Apr 15, 2024 |
3 |
-$105K |
4 |
Apr 17, 2024 |
Interim CEO & General Counsel |
IOVA |
IOVANCE BIOTHERAPEUTICS, INC. |
Mar 4, 2024 |
3 |
-$194K |
4 |
Mar 6, 2024 |
Interim CEO & General Counsel |
IOVA |
IOVANCE BIOTHERAPEUTICS, INC. |
Mar 1, 2024 |
2 |
$0 |
4 |
Mar 5, 2024 |
Interim CEO & General Counsel |
IOVA |
IOVANCE BIOTHERAPEUTICS, INC. |
Jan 16, 2024 |
3 |
-$54.7K |
4 |
Jan 18, 2024 |
Interim CEO & General Counsel |
IOVA |
IOVANCE BIOTHERAPEUTICS, INC. |
Oct 16, 2023 |
3 |
-$31.6K |
4 |
Oct 18, 2023 |
Interim CEO & General Counsel |
IOVA |
IOVANCE BIOTHERAPEUTICS, INC. |
Jul 14, 2023 |
3 |
-$68.7K |
4 |
Jul 17, 2023 |
Interim CEO & General Counsel |
IOVA |
IOVANCE BIOTHERAPEUTICS, INC. |
Apr 14, 2023 |
3 |
-$49.9K |
4 |
Apr 18, 2023 |
Interim CEO & General Counsel |
IOVA |
IOVANCE BIOTHERAPEUTICS, INC. |
Mar 2, 2023 |
2 |
$0 |
4 |
Mar 6, 2023 |
Interim CEO, President & General Counsel |
IOVA |
IOVANCE BIOTHERAPEUTICS, INC. |
Jan 17, 2023 |
3 |
-$234K |
4 |
Jan 19, 2023 |
Interim CEO & General Counsel |
IOVA |
IOVANCE BIOTHERAPEUTICS, INC. |
Nov 28, 2022 |
1 |
$5.98K |
4 |
Nov 28, 2022 |
Interim CEO & General Counsel |
IOVA |
IOVANCE BIOTHERAPEUTICS, INC. |
Jun 1, 2022 |
1 |
$6.44K |
4 |
Jun 2, 2022 |
Interim CEO & General Counsel |
IOVA |
IOVANCE BIOTHERAPEUTICS, INC. |
Jan 14, 2022 |
1 |
$0 |
4 |
Jan 19, 2022 |
Interim CEO & General Counsel |
IOVA |
IOVANCE BIOTHERAPEUTICS, INC. |
Jun 14, 2021 |
2 |
$0 |
4 |
Jun 16, 2021 |
Interim CEO & General Counsel |